{"id":"https://openalex.org/W2018599896","doi":"https://doi.org/10.1002/syn.21538","title":"Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB\u20101020: Implications for treatment of attention\u2010deficit hyperactivity disorder","display_name":"Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB\u20101020: Implications for treatment of attention\u2010deficit hyperactivity disorder","publication_year":2012,"publication_date":"2012-02-02","ids":{"openalex":"https://openalex.org/W2018599896","doi":"https://doi.org/10.1002/syn.21538","mag":"2018599896","pmid":"https://pubmed.ncbi.nlm.nih.gov/22298359"},"language":"en","primary_location":{"id":"doi:10.1002/syn.21538","doi":"https://doi.org/10.1002/syn.21538","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.21538","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110261041","display_name":"Frank P. Bymaster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Frank P. Bymaster","raw_affiliation_strings":["Euthymics Bioscience Inc., Thorndike St Suite S1-3, Cambridge, MA 02141, USA. fbymaster@euthymics.com","Euthymics Bioscience Inc., Thorndike St Suite S1-3, Cambridge, MA 02141"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Euthymics Bioscience Inc., Thorndike St Suite S1-3, Cambridge, MA 02141, USA. fbymaster@euthymics.com","institution_ids":[]},{"raw_affiliation_string":"Euthymics Bioscience Inc., Thorndike St Suite S1-3, Cambridge, MA 02141","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053954553","display_name":"Krystyna Go\u0142embiowska","orcid":"https://orcid.org/0000-0002-5018-1394","observed_orcids":["https://orcid.org/0000-0002-5018-1394"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Krystyna Golembiowska","raw_affiliation_strings":["Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101669339","display_name":"Magdalena Kowalska","orcid":"https://orcid.org/0000-0001-7950-5543","observed_orcids":["https://orcid.org/0000-0001-7950-5543"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena Kowalska","raw_affiliation_strings":["Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103205214","display_name":"Yong Kee Choi","orcid":"https://orcid.org/0000-0003-4411-3587","observed_orcids":["https://orcid.org/0000-0003-4411-3587"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yong Kee Choi","raw_affiliation_strings":["Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA; Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA 02478","Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA 02478","Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA; Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA 02478","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801148111","https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA 02478","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA","institution_ids":["https://openalex.org/I2801148111","https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081640744","display_name":"Frank I. Tarazi","orcid":"https://orcid.org/0000-0001-6839-9378","observed_orcids":["https://orcid.org/0000-0001-6839-9378"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Frank I. Tarazi","raw_affiliation_strings":["Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA; Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA 02478","Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA 02478","Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA; Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA 02478","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801148111","https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA 02478","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, MA","institution_ids":["https://openalex.org/I2801148111","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5081640744","https://openalex.org/A5110261041"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801148111","https://openalex.org/I4210087915"],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":0.7839,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.7027833,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"66","issue":"6","first_page":"522","last_page":"532"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/norepinephrine-transporter","display_name":"norepinephrine transporter","score":0.7910000085830688},{"id":"https://openalex.org/keywords/dopamine-transporter","display_name":"dopamine transporter","score":1.0},{"id":"https://openalex.org/keywords/monoamine-reuptake-inhibition","display_name":"monoamine reuptake inhibition","score":0.8610000014305115},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.972000002861023},{"id":"https://openalex.org/keywords/prefrontal-cortex","display_name":"prefrontal cortex","score":0.7239999771118164},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.996999979019165},{"id":"https://openalex.org/keywords/tail-suspension-test","display_name":"tail suspension test","score":0.7540000081062317},{"id":"https://openalex.org/keywords/locomotor-hyperactivity","display_name":"locomotor hyperactivity","score":0.8450000286102295},{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.9129999876022339},{"id":"https://openalex.org/keywords/neurotransmitter-release","display_name":"neurotransmitter release","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7437478303909302},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.7362042665481567},{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.7191839218139648},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.7062835693359375},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.6371181011199951},{"id":"https://openalex.org/C176233148","wikidata":"https://www.wikidata.org/wiki/Q14874257","display_name":"Norepinephrine transporter","level":4,"score":0.597558319568634},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.5826554894447327},{"id":"https://openalex.org/C2776755682","wikidata":"https://www.wikidata.org/wiki/Q2271947","display_name":"Dopamine transporter","level":4,"score":0.5816700458526611},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5281462669372559},{"id":"https://openalex.org/C2908949072","wikidata":"https://www.wikidata.org/wiki/Q899647","display_name":"Dopamine Uptake Inhibitors","level":4,"score":0.5078232884407043},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.4702008366584778},{"id":"https://openalex.org/C2780467756","wikidata":"https://www.wikidata.org/wiki/Q418970","display_name":"Reboxetine","level":5,"score":0.4679716229438782},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.4617716073989868},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46150118112564087},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4564421772956848},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3889702260494232},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.2919297516345978},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29059794545173645},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.2702730894088745},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.22960114479064941},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.16418713331222534},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.10100549459457397},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09299573302268982}],"mesh":[{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019417","descriptor_name":"Hindlimb Suspension","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/syn.21538","doi":"https://doi.org/10.1002/syn.21538","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.21538","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},{"id":"pmid:22298359","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22298359","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W51209413","https://openalex.org/W133846886","https://openalex.org/W138509012","https://openalex.org/W1865055600","https://openalex.org/W1968567868","https://openalex.org/W1968778095","https://openalex.org/W1970174017","https://openalex.org/W1971669832","https://openalex.org/W1971751319","https://openalex.org/W1972903772","https://openalex.org/W1975912352","https://openalex.org/W1978136073","https://openalex.org/W1982292219","https://openalex.org/W1986550480","https://openalex.org/W1992164809","https://openalex.org/W1997515330","https://openalex.org/W1998594730","https://openalex.org/W2005898434","https://openalex.org/W2008226573","https://openalex.org/W2016652500","https://openalex.org/W2017407904","https://openalex.org/W2027614967","https://openalex.org/W2029181852","https://openalex.org/W2037664489","https://openalex.org/W2039980027","https://openalex.org/W2040513075","https://openalex.org/W2044907318","https://openalex.org/W2046064455","https://openalex.org/W2046658074","https://openalex.org/W2050607595","https://openalex.org/W2052080148","https://openalex.org/W2053924394","https://openalex.org/W2056319469","https://openalex.org/W2057760214","https://openalex.org/W2064340252","https://openalex.org/W2070068773","https://openalex.org/W2071677128","https://openalex.org/W2079311820","https://openalex.org/W2079590493","https://openalex.org/W2080402976","https://openalex.org/W2090715212","https://openalex.org/W2091029144","https://openalex.org/W2092333411","https://openalex.org/W2093587140","https://openalex.org/W2095275475","https://openalex.org/W2095782630","https://openalex.org/W2113457968","https://openalex.org/W2114746853","https://openalex.org/W2122592499","https://openalex.org/W2124674986","https://openalex.org/W2126551185","https://openalex.org/W2127294790","https://openalex.org/W2130386846","https://openalex.org/W2138020206","https://openalex.org/W2142732083","https://openalex.org/W2143145606","https://openalex.org/W2151874528","https://openalex.org/W2154134749","https://openalex.org/W2155181385","https://openalex.org/W2159881136","https://openalex.org/W2160305158","https://openalex.org/W2171074660","https://openalex.org/W7073737076"],"related_works":["https://openalex.org/W7097282567","https://openalex.org/W2528062135","https://openalex.org/W2037664489","https://openalex.org/W2057760214","https://openalex.org/W2022035186","https://openalex.org/W2038506087","https://openalex.org/W2143145606","https://openalex.org/W2075329148","https://openalex.org/W1997244457","https://openalex.org/W4415471166"],"abstract_inverted_index":{"We":[0],"report":[1],"on":[2,76],"the":[3,73,85,101,123,137],"pharmacological,":[4],"behavioral,":[5],"and":[6,39,44,54,69,78,113,165],"neurochemical":[7],"characterization":[8],"of":[9,37,67,89,106,110],"a":[10,145],"novel":[11],"dual":[12],"norepinephrine":[13],"(NE)/dopamine":[14],"(DA)":[15],"transporter":[16],"inhibitor":[17],"EB-1020":[18,21,50,96,127,158],"(1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane":[19],"HCl).":[20],"preferentially":[22],"inhibited":[23,129],"monoamine":[24],"reuptake":[25],"in":[26,58,62,84,100,119,122,132,172],"cloned":[27],"cell":[28],"lines":[29],"transfected":[30],"with":[31,34,64,72,136],"human":[32],"transporters":[33],"IC\u2085\u2080":[35],"values":[36],"6":[38],"38,":[40],"respectively,":[41],"for":[42,149],"NE":[43,164],"DA":[45,55,81,166],"transporters.":[46],"In":[47],"microdialysis":[48],"studies,":[49],"markedly":[51],"increased":[52,80],"NE,":[53,77],"concentrations":[56,83],"levels":[57],"rat":[59],"prefrontal":[60],"cortex":[61],"vivo":[63],"peak":[65],"increases":[66],"375":[68],"300%,":[70],"respectively":[71],"greatest":[74],"effects":[75],"also":[79],"extracellular":[82],"striatum":[86],"to":[87,108],"400%":[88],"baseline":[90],"concentrations.":[91],"Behavioral":[92],"studies":[93],"demonstrated":[94],"that":[95,157],"dose-dependently":[97,128],"decreased":[98],"immobility":[99],"mouse":[102],"tail":[103],"suspension":[104],"test":[105],"depression":[107],"13%":[109],"control":[111],"levels,":[112],"did":[114],"not":[115],"stimulate":[116],"locomotor":[117,130],"activity":[118],"adult":[120],"rats":[121,134],"optimal":[124],"dose":[125],"range.":[126],"hyperactivity":[131,151],"juvenile":[133],"lesioned":[135],"neurotoxin":[138],"6-hydroxydopamine":[139],"(100":[140],"\u03bcg":[141],"intracisternally)":[142],"as":[143],"neonates;":[144],"well-established":[146],"animal":[147],"model":[148],"attention-deficit":[150],"disorder":[152],"(ADHD).":[153],"These":[154],"data":[155],"suggest":[156],"mediates":[159],"its":[160],"actions":[161],"by":[162],"stimulating":[163],"neurotransmission,":[167],"which":[168],"are":[169],"typically":[170],"impaired":[171],"ADHD.":[173]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}